Dianthus Therapeutics | MGTA - Stock

Aktienkurs
91.00
Täglich Wechseln
-0.29 -0.32%
Monatlich
15.85%
Jährlich
328.64%
Q2 Prognose
91.21




Stock Veränderung Datum
Akebia Therapeutics USD 15.61M 3.03M 2025-12
Avita Medical AUD 6.93M 614K 2025-12
Celltrion KRW 2.71T 121.94B 2025-06
Cspc Pharmaceutical CNY 2.87B 259.23M 2025-06
Divis Laboratories Ltd INR 32.36B 910M 2025-03
Kangmei Pharma CNY 2.45B 12.27M 2025-09
Knight Therapeutics CAD 95.4M 2.91M 2024-03
Laboratorios Farma EUR 327.67M 2.28M 2025-06
Medical Developments International AUD 9.45M 679K 2025-06
Moderna USD 332M 92M 2025-09
Organigram Holdings CAD 132.71M 8.76M 2025-12
Organon & Co USD 1.49B 34M 2025-09
Pharma Mar EUR 50.64M 1.13M 2025-12
Qiagen NV USD 290.23M 2.32M 2025-09
Revvity USD 379.5M 420K 2025-12
Sartorius EUR 827.1M 34.9M 2026-03
Sino Biopharmaceutical CNY 1.84B 156.17M 2024-06
Tilray USD 282.79M 11.9M 2025-06
Viatris USD 4B 112.2M 2025-12
Xeris Pharmaceuticals USD 68.67M 1.21M 2025-12
Zealand Pharma A/S 10.7M 9.9M 2024-12
Zz Pientze Pharmaceu CNY 5.72B 778.27M 2025-06